Hepatitis C virus infection in intravenous drug users

被引：17
|
作者：
Harder, J
Walter, E
Riecken, B
Ihling, C
Bauer, TM
机构：
[1] Univ Freiburg, Med Klin, Innere Med Abt 2, Dept Pathol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Univ Hosp, Dept Med Gastroenterol Hepatol & Infect Dis 2, Freiburg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期
关键词：
drug users; hepatitis C; liver function tests; liver histology;
D O I：
10.1111/j.1469-0691.2004.00934.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Intravenous drug use (IVDU) remains a major means of hepatitis C virus (HCV) transmission. In this study, 101 drug users were studied prospectively after cessation of IVDU. Of these, 75.8% were anti-HCV positive, and 71.4% had elevated levels of alanine aminotransferase. These levels decreased significantly within 1 month of IVDU cessation (p 0.02). Liver biopsies showed minimal or mild fibrosis in 32 (71%) of 45 subjects, and severe fibrosis in two (4.4%) subjects. Anti-HCV-positive intravenous drug users in this study presented with mild liver disease and variable stages of disease progression. Biochemical disease activity might be affected by IVDU.
引用
收藏
页码：768 / 770
页数：3
相关论文
共 50 条
  • [21] Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection
    Silva, Eliane
    Marques, Sara
    Leal, Barbara
    Canhao, Bernardo
    Madaleno, Joao
    Simao, Adelia
    Carvalho, Armando
    VIRUS RESEARCH, 2023, 329
  • [22] ANTIBODY PREVALENCE TO HEPATITIS-C AND PARENTERAL TRANSMITTED VIRUS DISEASES IN INTRAVENOUS-DRUG-USERS
    NEUWALD, C
    PONT, J
    TOMASITS, J
    BAUER, K
    ACTA MEDICA AUSTRIACA, 1992, 19 (02) : 47 - 48
  • [23] HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention
    Hagan, H
    Thiede, H
    Des Jarlais, DC
    AIDS, 2005, 19 : S199 - S207
  • [24] Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C
    Fabris, P
    Brown, D
    Tositti, G
    Bozzola, L
    Giordani, MT
    Bevilacqua, P
    de Lalla, F
    Webster, GJM
    Dusheiko, G
    JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (03) : 160 - 166
  • [25] Depressive symptoms are frequent among drug users, but not associated with hepatitis C infection
    Madsen, Lone W.
    Fabricius, Thilde
    Hjerrild, Simon
    Hansen, Thomas M.
    Mossner, Belinda K.
    Birkemose, Inge
    Skamling, Merete
    Christensen, Peer B.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 46 (08) : 566 - 572
  • [26] Hepatitis C in intravenous drug users: study of obstacles and facilitators to access to health care and services
    Foley, Veronique
    Petit, Genevieve
    Giraud, Marie-Josee
    Boisvert, Krystel
    Rietmann, Michele
    Brousselle, Astrid
    SANTE PUBLIQUE, 2016, 28 (03): : 363 - 374
  • [27] Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy
    Quaglio, GL
    Lugoboni, F
    Pajusco, B
    Sarti, M
    Talamini, G
    Mezzelani, P
    Des Jarlais, DC
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (05) : 394 - 400
  • [28] Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy
    Wang, Chih-Wen
    Chuang, Hung-Yi
    Chiang, Hung-Che
    Huang, Po-Chin
    Yu, Ming-Lung
    Dai, Chia-Yen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 454 - 460
  • [29] Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention
    Hutchinson, SJ
    Bird, SM
    Taylor, A
    Goldberg, DJ
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2006, 17 (03) : 211 - 221
  • [30] Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection
    Dore, GJ
    Thomas, DL
    SEMINARS IN LIVER DISEASE, 2005, 25 (01) : 18 - 32
12345